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8-hydroxyguanineHuntington disease (HD) is a neurodegenerative disease caused by expansion of CAG repeats in the
huntingtin (Htt) gene. The expression of hMTH1, the human hydrolase that degrades oxidized purine nucle-
oside triphosphates, grants protection in a chemical HD mouse model in which HD-like features are induced
by the mitochondrial toxin 3-nitropropionic acid (3-NP). To further examine the relationship between oxi-
dized dNTPs and HD-like neurodegeneration, we studied the effects of hMTH1 expression in a genetic cellular
model for HD, such as striatal cells expressing mutant htt (HdhQ111). hMTH1 expression protected these cells
from 3-NP and H2O2-induced killing, by counteracting the mutant htt-dependent increased vulnerability and
accumulation of nuclear and mitochondrial DNA 8-hydroxyguanine levels. hMTH1 expression reverted the
decreased mitochondrial membrane potential characteristic of HdhQ111 cells and delayed the increase in mi-
tochondrial reactive oxygen species associated with 3-NP treatment. Further indications of hMTH1-mediated
mitochondrial protection are the partial reversion of 3-NP-induced alterations in mitochondrial morphology
and the modulation of DRP1 and MFN1 proteins, which control fusion/ﬁssion rates of mitochondria. Finally,
in line with the in vitro ﬁndings, upon 3-NP in vivo treatment, 8-hydroxyguanine levels in mitochondrial DNA
from heart, muscle and brain are signiﬁcantly lower in transgenic hMTH1-expressing mice than in wild-type
animals.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Huntington disease (HD) is a progressive neurodegenerative dis-
order with autosomal dominant inheritance (Bates, 2005). The
cause of the disease is an abnormal expansion of CAG repeats in the
ﬁrst exon of the gene coding for huntingtin (Htt) (Group and
disease, 1993). The normal and expanded allele sizes have been de-
ﬁned respectively as CAG6–37 and CAG35–121 repeats and expression
of Htt with an extended polyglutamine (polyQ) stretch is harmful
and results in a selective neuronal loss in the brain, particularly in
the striatum.n; polyQ, polyglutamine; 3-NP,
xodG, 8-hydroxyguanine; DDR,
, Double strand breaks; DRP1,
ology andNeuroscience, Istituto
nment and Primary Prevention,
161 Rome, Italy. Fax: +39 06
i), margherita.bignami@iss.it
irect.com).
NC-ND license.3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate
dehydrogenase and a mitochondrial toxin, has been extensively used
as a chemical model for HD. The metabolic impairment produced by
3-NP is associated with oxidative stress (Fontaine et al., 2000). Both
in primates (Brouillet et al., 1995) and in mice (Brouillet et al.,
1999) chronic exposure to 3-NP is capable to replicate most of the
clinical and pathophysiological hallmarks of HD, including dystonic
movements, cognitive deﬁcits and progressive striatal degeneration.
Mice carrying wild-type HdhQ7 and mutant HdhQ111 knockin Htt
gene (Mangiarini et al., 1996; Wheeler et al., 1999), and striatal cell
lines derived from them (Trettel et al., 2000), provide alternative ex-
perimental HD models. Because the mutant Htt affects a variety of
cellular processes, the nature of the toxic insult is still not fully under-
stood. Indeed mutant Htt expression in both neuronal and
non-neuronal cells is highly pleiotropic. It is associated with major
changes in transcription, the formation of intraneuronal aggregates/
inclusion containing the abnormal protein, impaired intracellular
trafﬁcking and energy metabolism and increased oxidative DNA dam-
age (Browne and beal, 2006; DiFiglia et al., 1997; Lin and Beal, 2006;
Sorolla et al., 2008; Wyttenbach et al., 2002). Besides its direct effects,
mutant Htt expression is also known to increase the susceptibility to a
concomitant stressful challenge. Therefore, to fully depict the cell
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lenge. It is generally recognized that formation of reactive oxygen
species (ROS) and subsequent oxidative stress play a major role in
the neurodegeneration associated with HD (Bertoni et al., 2011;
Bogdanov et al., 2001; Browne et al., 1999; Giuliano et al., 2003;
Polidori et al., 1999). Increased oxidative damage to DNA, proteins
and lipids has been reported in HD both in humans and in mouse
models (for review see ref. Lin and Beal, 2006). In particular, ﬁndings
of increased levels of DNA 8-hydroxyguanine (8-oxodG) have been
reported in post-mortem brains of HD patients (Polidori et al.,
1999) and during the progression of the disease in R6/2 mice
(Bogdanov et al., 2001). Htt-associated oxidative stress is also accom-
panied by DNA breaks and activation of a DNA damage response
(DDR) identiﬁable in the accumulation of phosphorylated ATM/ATR
proteins in Htt-expressing PC12 cells or in ﬁbroblasts from HD pa-
tients (Bertoni et al., 2011; Giuliano et al., 2003).
Several DNA repair systems protect mammalian cells against the ac-
cumulation of 8-oxodG in the genome. The major one is the base exci-
sion repair (BER) pathway, which via the OGG1 glycosylase directly
removes this oxidized base from DNA. Another signiﬁcant level of pro-
tection is provided by a family of hydrolases which eliminates oxidized
precursors from the dNTP/NTP pool (Ishibashi et al., 2003). hMTH1,
the major human 8-oxodGTPase, degrades both 8-oxodGTP and
8-oxoGTP to the corresponding monophosphates, and prevents the in-
corporation of 8-oxoG into DNA and RNA (Hayakawa et al., 1999;
Sakumi et al., 1993). Studies with mth1−/− mice exposed to 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyrine identiﬁed a major protective role of
MTH1 in dopaminergic neurons in a mouse model for Parkinson's dis-
ease (Yamaguchi et al., 2006) and in hippocampal microglia during
kainate-induced excitotoxicity (Kajitani et al., 2006). Complementary
to these observations, transgenic mice expressing the humanMTH1 hy-
drolase are protected against 3-NP-induced HD-like striatal neuro-
degeneration and motor impairment (De Luca et al., 2008). In addition
hMTH1 expression in HdhQ111 progenitor striatal cell lines containing
Htt genewith expanded CAG repeats protected themagainst the toxicity
associated with the mutant Htt (Ventura et al., 2010). hMTH1 is local-
ized both in the cytosol and in themitochondrialmatrix and contributes
to the sanitization of both nuclear and mitochondrial dNTP pools (Kang
et al., 1995).In view of the effects of hMTH1 on these two targets,
here we report an investigation of the mechanisms underlying the
hMTH1-mediated defence against HD-associated neurodegenera-
tion. We show that although hMTH1 protects both nuclear and mi-
tochondrial cellular compartments against oxidative damage, the
major factor in hMTH1-mediated neuroprotection is improved mi-
tochondrial functionality.Methods
Striatal cell cultures, DNA transfection and measurements of cell death
Cells derived from wild-type and mutant htt knockin mice (HdhQ7
and HdhQ111) (Coriell Cell Repositories, Camden, NJ, US) were rou-
tinely grown at 33 °C in high-glucose DMEM (Lonza, Basel, CH)
supplemented with 10% fetal bovine serum, penicillin (100 U/ml),
and streptomycin (100 μg/ml) (complete medium). Following trans-
fection with Lipofectamine (Invitrogen Life Technologies, Carlsbad,
CA, USA) of exponentially growing HdhQ111 cells with pcDEBΔ (De
Luca et al., 2008), hygromycin-resistant clones were isolated after ap-
proximately 20 days growth in selective medium (200–300 mg/ml
Hygromycin, Roche, Basel, CH). Survival was determined by
clonogenic assay after a 24 hr treatment in serum-free DMEM with
3-NP or 15 min exposure to H2O2 in 20 mM Hepes containing com-
plete medium. Cultures (100–200 cells/dish) were treated with the
drug 18 hr after seeding, fed with complete medium and 1–2 weeks
later surviving colonies were ﬁxed, stained with Giemsa and counted.The number of colonies in treated cells was expressed as a percentage
of that in untreated cells.
Analysis of 8-oxodG by HPLC/EC
8-oxodG was measured by high-performance liquid chromatogra-
phy with electrochemical detection (HPLC/EC) following DNA extrac-
tion, RNase treatment, and enzymatic hydrolysis. DNA was extracted
by a high-salt protein precipitation method that avoids possible arti-
facts. Brieﬂy, cells were lysed in 1 ml of Tris–HCl 10 mM pH 8, EDTA
10 mM, NaCl 10 mM and SDS 0.5%, treated for 1 hr at 37 °C with
RNAse (20 μg/ml) and digested overnight with 1 mg/ml proteinase
K (Qiagen, Milan, Italy). Proteins were precipitated by adding NaCl
to 1.5 M, and DNA in the supernatant was collected by addition of 2
volumes of ethanol. The DNA pellet was resuspended in 10 mM
Tris-EDTA. Enzymatic digestion was then performed at 37 °C with nu-
clease P1 (Boehringer Mannheim, Monza, Italy) for 2 hr and alkaline
phosphatase (Boehringer Mannheim) for 1 hr. Enzymes were precip-
itated by addition of CHCl3, and the upper layer was stored for anal-
ysis of 8-oxodGua at 80 °C under N2.
Mitochondria from striatal cell lines were prepared using the Pierce
Mitochondrial isolation kit (Thermo Fisher Scientiﬁc, Rockford, IL, USA)
and mtDNA was prepared using the protocol described above. The
PromoKine Mitochondrial DNA isolation kit (PromoCell GmbH, Heidel-
berg, Germany) was used to isolate mtDNA from mouse tissues.
The DNA hydrolysate was analyzed by HPLC/EC (Coulochem; ESA
Inc., Thermo Scientiﬁc) with a C18 5 μm Uptishere column (250 by
46 mm; Interchim) equipped with a C18 guard column. The eluent
was 50 mM ammonium acetate, pH 5.5, containing 9% methanol, at a
ﬂow rate of 0.7 ml/min. The potentials applied were 150 and 400 mV
for E1 and E2, respectively. The retention time of 8-oxodG was
23 min. Deoxyguanosinewasmeasured in the same run of correspond-
ing 8-oxodGwith a UV detector (model SPD-2A; Shimadzu) at 256 nm;
the retention time was 17 min.
Western blot analysis
Cell extracts were prepared from 106 cells lysed in RIPA Buffer (Tris–
HCl 50 mM pH 7.4), NaCl 150 mM, EDTA 1 mM (pH 8), 1% NP40, NaF
1 mM, and a protease inhibitor cocktail tablets (Complete mini, Roche)
for 1 hr on ice and then centrifuged at 14,000 rpm for 30 min. Protein
concentration was evaluated using the Bradford method and 20–40 μg
of total extract was separated on SDS polyacrilamide gels, transferred
to nitrocellulosemembranes (Whatman)with a TransBlot cell apparatus
(Bio-Rad), and probed using the indicated primary antibodies: overnight
at 4 °Cwith rabbit anti-hMTH1 (1:500, a kind gift of Y. Nakabeppu), rab-
bit anti-DRP1 (1:500, Abcam, Cambridge, UK) and mouse anti-MFN1
(1:200, Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies
followed by the appropriate secondary antibody. ECL detection reagents
(Invitrogen) were used to develop the blots. Anti-PCNA (1:5000, Santa
Cruz Biotechnology) and anti-MnSOD (1:2000, Assay Designs/Stressgen,
Enzo Life Sciences) antibodies were used as loading controls.
Measurement of mitochondrial membrane potential (Δψm)
The potentiometric dye TMRE (tetramethylrhodamine ethyl ester
perchlorate) was used to estimate mitochondrial inner membrane po-
tential (Δψm) by the “redistribution” method (Duchen et al., 2003),
which is adequate for the comparison of Δψm between populations of
cells. Loading of the dye was achieved by keeping the cells for 30 min
in the presence of TMRE 30 nMbefore recording, in order to reach equi-
librium between cell compartments and between cytoplasm and extra-
cellular space (the external solution), where the loading concentration
of the dye wasmaintained throughout the experiment. The saline solu-
tion used for loading and recording had the following composition:
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HEPES/NaOH 10 mM (RT, pH 7.4, 290 mOsmol l−1).
An oil immersion objective (Olympus: 40×, 1.35 NA) mounted on
an inverted microscope (Axiovert 135, Zeiss; Germany) was utilized
for ﬂuorescence video imaging. An excitation wavelength of 535 nm
was applied by means of a monochromator (Till Photonics, Poly-
chrome II; Germany) and the emission light at 590 nM was collected
by a CCD, cooled digital camera (PCO, Sensicam; Germany) and
recorded on the hard disk of a PC computer. The Imaging Workbench
6.0 software package (Indec BioSystems; CA, USA) was used for re-
cording and off-line analysis of the data. The software allowed the
measurement of the emission values also along line proﬁles crossing
mitochondria. A minimum of two peaks of amplitude was used to cal-
culate the average amplitude of a given mitochondrion. Since the or-
ganelles were densely packed around a mitochondria-free area
corresponding to the nucleus and single mitochondria were detect-
able only in the periphery of a cell, only mitochondria in this latter
area were chosen for analysis. TMRE-loaded cultures were also used
to evaluate mitochondrial morphology and to classify the cells
accordingly.
ROS measurements
Proliferating striatal cell lines (2-4×105 cells in 60-mm dish) were
treated for increasing time periods with 3-NP 10 mM, washed with
PBS, incubated for 30 min in the dark at RT with CM-H2DCFDA
(10 μM ﬁnal concentration) (Invitrogen), trypsinized and resuspended
in PBS/EDTA. Mitochondrial ROS levels were quantiﬁed as described by
the manufacturer (Molecular Probes, Invitrogen). Before harvesting,
cells were incubated with MitoSOX™ Red reagent 5 μM (Molecular
Probes, Invitrogen) for 10 min. Cells were washed with PBS, collected,
and kept on ice in the dark for immediate detection with the ﬂow
cytometer. Fluorescencewasmeasured on a FACScan (Becton‐Dickinson,
BD Biosciences) using excitation/emission wavelengths of 485/535 nm,
and 510/580 nm for CM-H2DCFDA andMitoSox respectively. The values
were expressed as mean ﬂuorescence of the cell population.
Immunoﬂuorescence analysis
Cultures were ﬁxed with 4% PFA in PBS for 15 min. After ﬁxation,
cells were permeabilized with 0.2% Triton X-100 in PBS for 5 min at
RT and incubated, for the blocking step, for 60 min at RT with PBS
containing 3% BSA/0.1% Triton X-100. Cells were incubated with the
primary antibodies: anti-γ-H2AX (Millipore, Billerica, MA, USA)
(1:1000 dilution, 1 hr at RT), anti-MnSOD (1:600 dilution, 2 hr at
RT) (Assay Designs/Stressgen), and anti-DRP1 (1:500, Abcam). As
secondary antibodies, Goat anti-rabbit IgG FITC-conjugated (1:200,
Jackson ImmunoResearch Laboratories, Inc, West Grove, PA) were
used. Nuclei were stained using Hoechst-33258 (5 μg/ml for
20 min). Coverslips were mounted with Vectashield Mounting Medi-
um and examined using an Eclipse 80i Nikon Fluorescence Micro-
scope, equipped with a VideoConfocal (ViCo) system or examined
using a Leica DM4000B ﬂuorescence microscope equipped with a
DFC420C digital camera and Leica Application Suite Software
(260RI) for image acquisition (Leica, Wetzlar, Germany). For analysis
of γ-H2AX foci, at least 200 nuclei were examined, and foci were
scored at ×60 magniﬁcation. Only nuclei showing more than ﬁve
bright foci were counted as positive.
In vivo treatment with 3-NP
Animal care, genotyping and all animal procedures were carried
out according to EU Directive 86/609/EEC and to Italian legislation
on animal experimentation. A previously described colony of
hMTH1-Tg mice was generated at our Institute and hMTH1-Tg ani-
mals were genotyped as previously reported (De Luca et al., 2008).All animals were housed under standardized temperature, humidity
and on a 12 hr light-12 hr dark cycle with free access to water and
food. 3-NP (Sigma-Aldrich, Milan, Italy) was dissolved in PBS (pH ad-
justed with NaOH) and administered twice a day (9.00 am and
16.00 pm) at the dose of 60 mg/kg i.p. Wild-type and hMTH1-Tg
mice were used. Baseline body weight was determined before the
start of the experiment and weight was monitored daily, immediately
before the 9.00 injection. Animals were killed by decapitation 16 hr
after the last injection and muscle, heart and brain areas were re-
moved and immediately frozen in liquid nitrogen.
Results
hMTH1 protects against mutant Htt-associated cell death during oxida-
tive stress
We have previously shown that hMTH1 overexpression reverted
the increased sensitivity of HdhQ111 cells towards 3-NP induced oxi-
dative stress, without signiﬁcantly affecting killing in HdhQ7 cells
(De Luca et al., 2008). Here we investigated the molecular mecha-
nisms underlying the protective role provided by hMTH1 against
Htt-mediated changes, in an early-passage clone of HdhQ111 cells
(passage 7) transfected with hMTH1 cDNA.
A pooled population of clones expressing hMTH1was used for com-
parative studies with the parental cells as well as the wild-type HdhQ7
striatal cells. Levels of hMTH1 expression were similar to those previ-
ously published and obtained in an hMTH1-transfectant clone derived
from late passage HdhQ111 cells (>20 passages) (Fig. 1A) (De Luca et
al., 2008). As expected, the mouse MTH1 protein was not detectable
in western blots probed with an antibody raised against hMTH1.
HdhQ111 cells are more sensitive than wild-type HdhQ7 cells to killing
by 3-NP (Gines et al., 2003; Ruan et al., 2004), and this sensitivity is re-
versed by hMTH1 overexpression (De Luca et al., 2008). These ﬁndings
were conﬁrmed in the low-passage hMTH1-expressing HdhQ111 cells
(Fig. 1B). hMTH1 expression also protected HdhQ111 cells against
H2O2-induced death (Fig. 1C). Thus hMTH1 defence is not limited to
cell death induced by a selective mitochondrial toxin, but it is effective
also against a more generalized state of oxidative stress induced by an
unspeciﬁc toxic agent such as H2O2.
hMTH1 reduces 8-oxodG levels in mitochondrial and nuclear DNA
To examine whether hMTH1 expression inﬂuenced DNA 8-oxodG
levels, we measured steady-state and oxidant-induced 8-oxodG in
nuclear as well as in mitochondrial DNA (mtDNA). In agreement with
several reports (Richter et al., 1988; Souza-Pinto et al., 2001) basal levels
of 8-oxo-dG were higher in mitochondrial than in nuclear DNA —
approximately 1.5-fold in each of the striatal cell lines (Figs. 2A and B,
control bars). Furthermore, expression of the mutant Htt gene in
HdhQ111 cells is associated with an additional 1.5-fold increase in both
nuclear and mtDNA 8-oxodG oxidation. hMTH1 expression in HdhQ111
transfectants decreased DNA 8-oxo-dG towild-type levels in both cellu-
lar compartments (Figs. 2A and B).
A 24 hr exposure to 3-NP (2.5 and 10 mM) induced a clear dose-
dependent increase in mtDNA 8-oxodG (increases ranging from 3 to
>5-fold) (Figs. 2A and B). Expression of mutant Htt resulted in higher
levels of mtDNA oxidation in comparison to wild-type cells (1.5-fold)
and this increase was reverted by hMTH1 expression (Fig. 2B). In con-
trast, 3-NP-induced oxidation was less pronounced in nuclear DNA,
with no differential oxidation in cells expressing mutant Htt and/or
hMTH1 expression (Fig. 2A).
Following exposure to H2O2 (range 0.25–1 mM) levels of 8-oxodG
increased in both nuclear and mitochondrial DNA and expression of a
mutant Htt was generally associated with enhanced DNA 8-oxo-dG
levels (Figs. 3A and B). hMTH1 conferred signiﬁcant protection
against nuclear DNA oxidation over a range of H2O2 concentrations
Fig. 1. Protection conferred by hMTH1 against cytotoxicity induced by 3-NP and H2O2.
A. Early passage (passage 7) HdhQ111 striatal cells (lane 5) were transfected with
hMTH1 cDNA (lane 4) and proteins were separated and probed with an antibody
against hMTH1. hMTH1 expression in the neuroblastoma SH-SY5Y cell line, (lane 3),
late passage HdhQ111 cells (lane 2) and their hMTH1 transfectant (lane 1) is shown
for comparison. B. Survival measured by clonal assays in HdhQ7, HdhQ111 and
HdhQ111–hMTH1 cells after a 24 hr exposure to 3-NP. C. Survival measured by clonal
assays in HdhQ7, HdhQ111 and HdhQ111–hMTH1 cells after a 15 min exposure to H2O2.
Data are the mean±SE from 3 experiments. The asterisks indicate signiﬁcant differ-
ences by Student's t-test (pb0.05).
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observed only in cells exposed to the lowest H2O2 dose (0.25 mM)
(Fig. 3B), although a similar trend was evident following exposure
to highly toxic H2O2 doses (0.5 and 1 mM). It is possible that the pro-
tection provided by hMTH1 is masked by the high variability in the
cellular response to highly toxic H2O2 doses (Fig. 3B).We conclude from these data that sanitization of the dNTP pool by
hMTH1 protects both nuclear and mitochondrial DNA from the in-
creased susceptibility to oxidation due to Htt-expression.
Modulation of γH2AX foci by Htt and hMTH1
To examine whether the Htt-dependent increase in steady-state
DNA oxidation resulted in the formation of DNA double strand breaks
(DSBs), γH2AX fociweremeasured in striatal cells. In the absence of ex-
ogenous oxidant, a signiﬁcantly higher percentage of HdhQ111 cells than
HdhQ7 cells were γH2AX-positive. hMTH1 expression in HdhQ111 cells
reverted this type of DNA damage to the levels observed in HdhQ7
cells (Fig. 4).
3-NP treatment increased the fraction of γH2AX foci-positive HdhQ7
and HdhQ111 cells. hMTH1 expression in HdhQ111 cells was associated
with a signiﬁcant reduction in the frequency of positive cells (Fig. 4A).
In contrast these effects were not appreciated in H2O2-treated cells
and both the Htt-dependent increase and the hMTH1-dependent re-
duction in the number ofγH2AX-positive cellswere not statistically sig-
niﬁcant in the three cell populations (Fig. 4B). Thus it is possible that a
large fraction of these breaks derives from direct DNA strand breakage
and is not affected by the level of oxidized dNTPs.
As before hMTH1 expression counteracts the Htt-dependent in-
crease in DSBs generated by oxidative stress. Furthermore we conﬁrm
the speciﬁc susceptibility of HdhQ111 cells to mitochondrial damage
induced by 3NP.
hMTH1 expression alters mitochondrial membrane potential
The mitochondrial dysfunction in striatal neurons of HD is associat-
ed with a lower membrane potential and depolarization at lower calci-
um loads thanmitochondria fromcontrols (Lim et al., 2008; Panov et al.,
2002). SimilarlymutantHtt expression inHdhQ111 cells has been shown
to be associated with a lower mitochondrial inner membrane potential
(Δψm) compared to HdhQ7 cells (Lim et al., 2008) and this observation
was conﬁrmed in our experimental conditions (data not shown). Here
we investigated whether hMTH1 expression could inﬂuence the affect-
edmitochondrialmembrane potential in HdhQ111 cells. For the analysis,
performed by the TMRE “redistribution” method, single mitochondria
located at the cell periphery were chosen (Fig. 5A). hMTH1 expressing
cells showed a signiﬁcantly higher TMRE ﬂuorescence signal (pb0.01)
in comparison to the parental HdhQ111 cells (Fig. 5B), thus suggesting
that the respiratory chain dysfunction caused bymutant Htt expression
is reversed by hMTH1 overexpression.
Reactive oxygen species measurements
Expression of a mutant Htt protein in neuronal cells is associated
with increased ROS levels (Bogdanov et al., 2001; Hands et al., 2011;
Polidori et al., 1999; Tabrizi et al., 2000; Firdaus et al., 2006). To investi-
gatewhether hMTH1 expression inﬂuenced ROS production, intracellu-
lar ROS were measured by two ﬂuorogenic dyes, the chloromethyl
derivative of dihydroﬂuorescein diacetate (CM-H2DCFDA) and
MitoSOX staining. The ﬁrst one is a nonﬂuorescent dye that is oxidized
into highly green ﬂuorescence when reacting with peroxides or
peroxide-derived reactive species, while the second one detects super-
oxides in the mitochondria of live cells. The intensity of ﬂuorescence
generated by these dyes is proportional to the amount of ROS and can
be quantiﬁed by FACS analysis (Mukhopadhyay et al., 2007). Examples
are shown in Figs. 6A and B. HdhQ111 and hMTH1-HdhQ111 cells showed
similar basal ROS levels as measured by CM-H2DCFDA and MitoSOX
(Figs. 6C and D, 0 hr). Exposure to 10 mM 3-NP for 1, 3 or 6 hr resulted
in a signiﬁcant increase in ROS production in both cell lines. This in-
crease was unaffected by hMTH1 expression when total cellular ROS
were evaluated (Fig. 6C), while a signiﬁcant decrease was observed in
the levels of mitochondrial ROS detected byMitoSOX staining (Fig. 6D).
Fig. 2. Levels of 8-oxodG measured by HPLC-EC in striatal cell lines exposed to 3-NP. 8-oxodG was measured in nuclear (A) and mtDNA (B) extracted from HdhQ7 (open bar),
HdhQ111 (black bar) and HdhQ111–hMTH1 (gray bar) cells either untreated or following a 24 hr exposure to 2.5 and 10 mM 3-NP. Data are the mean±SE from 3 experiments.
The asterisks indicate signiﬁcant differences by Student's t-test (*pb0.05; **pb0.01; ***pb0.001).
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overall steady-state ROS levels, it does decrease the production of
ROS in response to a mitochondrial toxin such 3-NP. Increased ROS
levels can be considered an early sign of mitochondrial dysfunction
(Liot et al., 2009), and our data indicate that hMTH1 confers signiﬁ-
cant protection against the effects of this mitochondrial toxin that
dramatically affects mitochondria bioenergetics.hMTH1 affects mitochondrial morphology
3-NP-induced mitochondrial dysfunction can be accompanied by
changes in mitochondrial morphology (Liot et al., 2009). ConfocalFig. 3. Levels of 8-oxodG measured by HPLC-EC in striatal cell lines exposed to H2O2. 8-ox
HdhQ111 (black bar) and HdhQ111–hMTH1 (grey bar) cells either untreated or following a 15
The asterisks indicate signiﬁcant differences by Student's t-test (*pb0.05; **pb0.01).imaging was used to determine whether hMTH1 induced protection
was paralleled by changes in mitochondrial morphology.
Immunoﬂuorescence examination indicated that untreatedHdhQ111
and HdhQ111–hMTH1 striatal cells all contained mitochondria with a
clear reticular/ramiﬁed (rod-like) shape, and very few spherical mito-
chondria, which are a typical sign of mitochondrial dysfunction, were
observed (Figs. 7A and B).
A completely different picture emerged when cells were challenged
for 24 hr with 10 mM 3-NP (Figs. 7C and D). This treatment caused a
striking effect on mitochondrial morphology, with a major shift from
the reticular/ramiﬁed shape to the dysfunctional spherical one in both
cell lines. Single cells were then analyzed by thorough visual inspection
for the different shapes of theirmitochondria and classiﬁed accordingly.odG was measured in nuclear (A) and mtDNA (B) extracted from HdhQ7 (open bar),
min exposure to 0.25, 0.5 and 1 mM H2O2. Data are the mean±SE from 3 experiments.
Fig. 4. Induction of γH2AX foci by 3-NP and H2O2 in HdhQ7, HdhQ111 and HdhQ111–hMTH1 cells. A. The number of cells positive for γH2AX foci was determined in the striatal cell
lines exposed for 24 hr to 0 (control), 2.5 and 10 mM 3-NP in serum-free media. B. The number of cells positive for γH2AX foci was determined in the striatal cell lines either
untreated or exposed for 15 min to increasing concentrations of H2O2. Data are the mean±SE from 3 experiments. The asterisks indicate signiﬁcant differences by Student's
t-test (pb0.01). HdhQ7 (open bar), HdhQ111 (black bar) and HdhQ111–hMTH1 (gray bar).
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spherical point-like (diameter up to 1 μm) and a spherical vesicular-
like shape. The last two are typical of stressed mitochondria (examples
of the three shapes are shown in Fig. 7E). After 3-NP treatment, cells
containing only reticular-shaped mitochondria were rare in the
HdhQ111 and HdhQ111–hMTH1 cell lines (Fig. 7F). hMTH1 expression
was associated with a signiﬁcantly higher proportion of cells with
mixed reticular/spherical mitochondria and a lower proportion of
spherical mitochondria compared to the parental HdhQ111 cell line
(Fig. 7F).
These changes in mitochondrial morphology indicate that hMTH1
protects HdhQ111 against mitochondrial stress and consequent
dysfunction.Fig. 5.Measurement of mitochondrial membrane potential in HdhQ111 and HdhQ111–hMTH1
dria (arrows) chosen for membrane potential measurement. B. TMRE-loaded cells were exci
cence signals in single mitochondria were averaged and shown in the graph as indication
indicate signiﬁcant differences by Student's t-test (pb0.01). HdhQ111 (black bar) and HdhQ1hMTH1 expression affects mitochondrial dynamics
Mitochondrial structural abnormalities in HD are accompanied by
alterations in the equilibrium between the two opposing events of or-
ganelle ﬁssion and fusion (Johri and Beal, 2012; Song et al., 2011). To
verify whether the observed hMTH1-associated changes in mitochon-
drial shape and size were accompanied by alterations of mitochondri-
al dynamics, we examined the expression of the dynamin-related
protein (DRP1) and mitofusin 1 (MFN1), two of the primary proteins
controlling respectively mitochondrial ﬁssion and fusion, in the
striatal cell lines. Comparison by western blotting indicated that mi-
tochondria from HdhQ111 cells contained more DRP1 than those of
hMTH1-expressing cells (Fig. 8A). The effect of hMTH1 expressioncells. A. The panel shows a TMRE-loaded HdhQ111 cell with single peripheral mitochon-
ted with 535 λ and ﬂuorescence intensity was recorded. The amplitudes of the ﬂuores-
of Δψm in the three cell lines. Data are the mean±SE from 4 experiments. Asterisks
11–hMTH1 (gray bar).
Fig. 6. Measurements by ﬂow cytometry of total and mitochondrial ROS in HdhQ111 and HdhQ111–hMTH1 cells. Analysis by ﬂow cytometry of CM-H2DCFDA (A) and MitoSOX (B)
ﬂuorescence in an untreated and 3-NP-treated HdhQ111 cell population. Cytoﬂuorimetric determinations of total ROS by CM-H2DCFDA (C) and mitochondrial ROS by MitoSOX (D)
in HdhQ111 and HdhQ111–hMTH1 cells either untreated or exposed for 1, 3 and 6 hr to 10 mM 3-NP. Data are the mean±SE from 3 experiments. The asterisks indicate signiﬁcant
differences by Student's t-test (pb0.05). HdhQ111 (open square) and HdhQ111–hMTH1 (closed square).
154 I. Ventura et al. / Neurobiology of Disease 49 (2013) 148–158on DRP1 mitochondrial localization in HdhQ111 cells was conﬁrmed
by immunoﬂuorescence analysis (Fig. 8B) showing a more diffuse
DRP1 labelling in hMTH1 expressing cells. hMTH1 expression had
the reverse effect on the level of the pro-fusion MFN1 protein and
MNF1 levels were increased in HdhQ111–hMTH1 cells when com-
pared to the parental cells (Fig. 8C).
The changes we observed in DRP1 and MFN1 levels indicate that
hMTH1 expression shifts the equilibrium of mitochondrial ﬁssion
and fusion proteins towards a more favourable dynamic.
In vivo protection of mitochondria by hMTH1
Since the protective role of hMTH1 towards mitochondrial dys-
function of HdhQ111 cells was investigated in proliferating cells in
vitro, we examined whether hMTH1 expression protected mtDNA
also in vivo by using a transgenic mouse expressing hMTH1 in several
organs. These mice are resistant to neurodegeneration induced by a
5-day chronic exposure to 3-NP (De Luca et al., 2008). Since no quan-
titative information is available on this protection at DNA level, here
we isolated mitochondria from different brain areas as well as from
heart and skeletal muscles and measured 8-oxodG levels in mtDNA
in untreated animals or following a 2-day exposure to 3-NP
(Figs. 9A–E). Compared to wild-type animals a signiﬁcantly lower
basal level of mtDNA 8-oxodG was observed in the striatum, hippo-
campus, heart and muscles of hMTH1-Tg animals. The single excep-
tion was the cortex where no difference was observed between the
two genotypes.
Following treatment with 3-NP (2 daily injections of 60 mg/kg) the
differential mtDNA oxidation between the two genotypes was
maintained. The ratios between 8-oxodG levels in wild-type andhMTH1-Tg mice were 1.4-fold in striatum and hippocampus (pb0.04
and pb0.05, Student's t-test), 1.5-fold in muscle (pb0.02, Student's
t-test) and 1.7-fold in the heart (pb0.004, Student's t-test). A similar
trend, but with no statistical signiﬁcance was observed in the cortex
(Figs. 9A–E).
These results indicate that hMTH1 protects mtDNA from both en-
dogenous and 3-NP-induced oxidation in the intact animal.
Discussion
Transcriptional dysregulation, protein aggregation, oxidative stress
and mitochondrial abnormalities have all been proposed as contributors
to neurodegeneration inHD. The resultswepresent here indicate that the
hMTH1 hydrolase represents a major protective element against oxida-
tive damage and mitochondrial dysfunctions associated with expression
of mutant Htt in striatal cells. Mutant Htt expression causes oxidative
stress (for a review see ref. Browne et al., 1999) and oxidized DNA
bases, lipids (e.g. F2-isoprostanes) and proteins accumulate in HD pa-
tients and in mouse models for HD (Bogdanov et al., 2001; Giuliano et
al., 2003; Sorolla et al., 2010). Our data show that Htt expression is asso-
ciated with increased DNA 8-oxodG in both nuclei and mitochondria.
Both these targets are protected by hMTH1. Although mtDNA synthesis
occurs independently fromnuclear DNA replication, the deoxynucleotide
pools for nuclear and mtDNA synthesis are in a dynamic equilibrium
(Leanza et al., 2008). The mitochondrial dNTP pool may however be
more at risk of oxidation because of its proximity to superoxide anions
leaking from the respiratory chain, particularly during anomalous mito-
chondrial activity. The double localization of an 8-oxodGTPase in the mi-
tochondrial matrix as well as in the cytosol indicates its likely
involvement in protecting the genetic integrity of mtDNA.
Fig. 7. Morphological changes in mitochondria induced by exposure of HdhQ111 and HdhQ111–hMTH1 cells to 3-NP. Mitochondrial morphology was visualized by confocal immu-
noﬂuorescence in cells labelled with the superoxide dismutase type 2 (Mn-SOD) antibody. Untreated HdhQ111 (A) and HdhQ111–hMTH1 (B) cells are shown above the same cell
lines (C and D, respectively) treated for 24 hr with 10 mM 3-NP. Examples of spheric, reticular/spheric and reticular mitochondria visualized in TMRE-loaded cells are shown in
E. The percentage of cells showing the different mitochondrial morphologies (F) are indicated in HdhQ111 and HdhQ111–hMTH1 cells after 24 hr exposure to 10 mM 3-NP, depicting
an increase of cells with reticular and a decrease of cells with spherical mitochondria induced by hMTH1 (*pb0.05; ***pb0.001).
155I. Ventura et al. / Neurobiology of Disease 49 (2013) 148–158Oxidative stress associatedwithmitochondrial impairment has been
identiﬁed as an early event in HD ethiopathogenesis (Bossy-Wetzel et
al., 2008; Browne and Beal, 2004). The phenotype of HD cells might re-
ﬂect a direct interaction of polyQ-expanded Htt protein with mitochon-
dria. The mitochondria related changes include dysfunctional Ca2+
homeostasis, with abnormal permeability transition pore opening
(Milakovic et al., 2006), increased ROS production exacerbated by com-
plex II inhibitors such as 3-NP, and a failure to maintain a balance be-
tween mitochondrial ﬁssion and fusion (Cui et al., 2006; Song et al.,
2011). These features of mutant Htt expressing cells were all retained
in HdhQ111 striatal cells.
Consistent with a role in maintaining healthy mitochondria, hMTH1
expression resulted in a highermembrane potential at steady state level
and a decreased production of mitochondrial ROS following 3-NP treat-
ment. These features were associated with a larger proportion of mito-
chondria in a ﬁlamentous mitochondrial morphology, which correlates
with a shifted equilibrium towards fusion in the balance between
fusion/ﬁssion of mitochondria and a higher bioenergetic efﬁciency of
mitochondria.
Moreover, mutant htt has been shown to enhance the expression
of NMDA-receptor 2B subtype in medium sized spiny neurons, ren-
dering this particular neuronal population the most susceptible to
excitotoxicity among striatal neurons (Fan and Raymond, 2007). In
consideration of the involvement of mitochondria in the excitotoxic
pathway, mitochondrial protection provided by hMTH1 would con-
tribute to counteract excitotoxic neuronal degeneration in HD.hMTH1 sanitizes the dNTP pool by degrading oxidized DNA pre-
cursors. This role is entirely consistent with the decreased mtDNA ox-
idation we observed. It is well known that Htt acts as a transcriptional
regulator of nuclear genes (Sugars and Rubinsztein, 2003), including
the major transcriptional regulator of mitochondrial biogenesis per-
oxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α
(Cui et al., 2006)). Thus the protection provided by hMTH1 towards
mitochondria might beneﬁt from the double protective role of this re-
pair enzyme on the stability of both nuclear and mtDNA.
3-NP induces a relatively modest increase in nuclear DNA 8-oxodG,
which is unaffected by either mutant Htt or hMTH1 expression. This re-
sult is intriguing when we consider the parallel accumulation of DSBs
identiﬁed by γH2AX foci and modulated by expression of polyQ Htt
and hMTH1. Then the question comes up on themechanismunderlying
these DNA breaks. The occurrence of DNA fragmentation associated
with expression of polyQ-expanded Htt has been reported both in
vitro (Bertoni et al., 2011) and in vivo (Butterworth et al., 1998; Kim
and Chan, 2001). In addition it has been shown that polyQ-expanded
proteins rapidly induce ROS and a signiﬁcant ATM/ATR mediated DDR
(Bertoni et al., 2011; Giuliano et al., 2003). Intriguingly, in the absence
of 3-NP exposure, hMTH1 overexpression fully reverts accumulation
of γH2AX foci in HdhQ111 cells, suggesting that the DDR triggered by
polyQ-expanded Htt speciﬁcally derives from intermediates arising
during repair of incorporated 8-oxoG from the dNTP pool. In contrast fol-
lowing 3-NP exposure suppression of DNA breaks by hMTH1 is only par-
tial, possibly because treatment with this toxin combinedwith polyQ Htt
Fig. 8. Analysis ofmitochondrial ﬁssion and fusion. A.Western blot analysis of the DRP1 ﬁssion protein inmitochondrial extracts prepared fromHdhQ111 andHdhQ111–hMTH1 cells. DRP1/
Mn-SOD ratios are shown in the graph. Error bars indicate mean±SE from three independent determinations. Asterisks indicate signiﬁcant differences by Student's t-test (*pb0.05).
HdhQ111 (black bar) and HdhQ111–hMTH1 (grey bar). B. Immunoﬂuorescence analysis of the DRP1 protein, indicating a different expression and distribution of the protein in HdhQ111
and HdhQ111–hMTH1 cells. C. Western blot analysis of the MNF1 fusion protein in cell-free extracts prepared from HdhQ111 and HdhQ111–hMTH1 cells. MNF1/PCNA ratios are shown in
the graph. Error bars indicate mean±SE from four independent determinations. The asterisks indicate signiﬁcant differences by Student's t-test (*pb0.05). HdhQ111 (black bar) and
HdhQ111–hMTH1 (gray bar).
Fig. 9. Levels of 8-oxodG inmtDNA fromseveral organs ofwild-type andhMTH1-Tgmice. Groups ofwild-type (n=15) andhMTH1-Tgmice (n=15) that had received saline injections or 3-NP
(60 mg/kg) twice daily for 2 dayswere sacriﬁced and levels of 8-oxo-dGwere determined by HPLC-EC inmtDNA prepared from striatum (A), hippocampus (B), cortex (C), heart (D) andmus-
cles (E) heart. Values are indicated as mean±S E. The asterisks indicate signiﬁcant differences by Student's t-test (*pb0.05; **pb0.01). Wild-type (black bar) and hMTH1-Tg mice (open bar).
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157I. Ventura et al. / Neurobiology of Disease 49 (2013) 148–158expression generates additional oxidative DNA lesions whose repair in-
termediates may equally well trigger a more sustained DDR.
We (De Luca et al., 2008) and others (Kajitani et al., 2006) have
shown that hMTH1 expression reduces the level of mRNA oxidation
in vivo. Since transcriptional errors caused by oxidative damage are
counteracted by hMTH1 (Hori et al., 2010; Ishibashi et al., 2005),
elimination of 8-oxoGTP from the precursors pool may also ensure
more accurate protein synthesis. An excess of carbonylated proteins,
particularly among mitochondrial proteins, is a feature of cells ex-
pressing the polyQ Htt protein (Browne et al., 1999; Perluigi et al.,
2005; Tunez et al., 2011) and synthesis of aberrant proteins because
of reduced transcriptional ﬁdelity might also favour protein oxidation
(Dukan et al., 2000). By analogy to the function of the E. coli MutT
protein (Dukan et al., 2000), it is possible that the protective role of
hMTH1 towards mutant Htt-associated dysfunction of mitochondria
might derive from the pleiotropic role of the repair enzyme.
Finally it is widely accepted that oxidative stress associated with
expression of mutant Htt ultimately leads to neuronal cell death.
The increased survival of hMTH1-expressing HdhQ111 striatal cells fol-
lowing exogenous oxidative stress (3-NP or H2O2) is consistent with
the pool of oxidized dNTP/NTPs being a major contributor to the neu-
rodegenerative process occurring in HD.
All the experiments demonstrating the protective role of hMTH1 in
the genetic model for HD were performed in active proliferating cells.
We were however able to demonstrate that hMTH1 expression signiﬁ-
cantly diminishes also DNA damage atmitochondrial level in differentiat-
ed tissues in vivo (brain, heart and muscles) both at steady state and
following 3-NP exposure. Indeed heart, similarly to the brain, has a tre-
mendous dependence on mitochondrial function and oxidative metabo-
lism and mitochondria in both these organs have been shown to be
major targets for 3-NP toxicity (Gabrielson et al., 2001). The efﬁciency
of hMTH1 in protecting mtDNA in a condition of strong oxidative stress
such as 3-NP treatment is noteworthy and suggests that the protective
role of hMTH1 we previously identiﬁed against 3-NP-induced neuro-
degeneration (De Luca et al., 2008) can be mostly ascribed to mitochon-
dria protection. It is worthwhile to stress that in the experimental
conditions used in this study the length of exposure to the mitochondrial
toxin was relatively short when compared to the time needed to observe
the neurological symptoms of HD (2 versus 5 days). In the absence of
early signs of toxicity (including weight loss), a signiﬁcant increase of
8-oxodG levels was observed in all the investigated tissues. All these ob-
servations on DNA damage are consistent with the hypothesis of oxida-
tive stress as one of the early events in 3-NP toxicity, which precedes
clinical symptoms.
We conclude that the hMTH1-mediated maintenance of mtDNA
stability protects cells from the exacerbated susceptibility to oxidant
injury associated with expression of a polyQ-expanded Htt protein,
but also defends the organism against the in vivo process of 3-NP-
induced neurodegeneration in the mouse model for HD.
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